MedTrace Logo

The Human Epilepsy Project

NCT02126774 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 488

Last updated 2021-07-06

No results posted yet for this study

Summary

HEP is a five-year, prospective, observational study whose primary goal is to identify clinical characteristics and biomarkers predictive of disease outcome, progression, and treatment response in participants with newly treated focal epilepsy.

Conditions

  • Focal Epilepsy

Sponsors & Collaborators

Principal Investigators

  • Ruben Kuzniecky, MD · New York University, Comprehensive Epilepsy Center

  • Jacqueline French, MD · New York University, Comprehensive Epilepsy Center

  • Daniel Lowenstein, MD · University of California, San Francisco, Department of Neurology

Eligibility

Min Age
12 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2020-03-31
Completion
2021-07-01

Countries

  • United States
  • Australia
  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02126774 on ClinicalTrials.gov